Literature DB >> 22495371

Concordance between tissue microarray and whole-section estrogen receptor expression and intratumoral heterogeneity.

H Evin Gulbahce1, Roberto Gamez, Leah Dvorak, Colleen Forster, Linda Varghese.   

Abstract

Hormone receptor status determination for breast cancer is an important part of pathologists' daily sign outs and many retrospective and prospective studies. In this study, we compared the estrogen receptor (ER) expression tested on tissue microarray (TMA) sections to those tested on whole sections (WS) to find out concordance and frequency of intratumoral heterogeneity. Five and one-half percent of all tumors showed discrepancy in ER expression between TMA and WS. The rate of discrepancy was lower with increasing number of cores from individual cases. In 1.4% of cases, there was discrepancy in ER expression between cores in which >1 core was available on TMA section. We concluded that TMA can be used to determine ER status with good concordance to ER determination done on WS. Whenever the size of the tumor in the block allows it, more cores should be taken to construct TMAs.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22495371     DOI: 10.1097/PAI.0b013e318241ca14

Source DB:  PubMed          Journal:  Appl Immunohistochem Mol Morphol        ISSN: 1533-4058


  3 in total

1.  Comparison of TMA Technique and Routine Whole Slide Analysis in Evaluation of Proliferative Markers Expression in Laryngeal Squamous Cell Cancer.

Authors:  Urszula Ciesielska; Aleksandra Piotrowska; Christopher Kobierzycki; Wojciech Pastuszewski; Marzenna Podhorska-Okolow; Piotr Dziegiel; Katarzyna Nowinska
Journal:  In Vivo       Date:  2020 Nov-Dec       Impact factor: 2.155

2.  Nectin-4 Expression Is an Independent Prognostic Biomarker and Associated With Better Survival in Triple-Negative Breast Cancer.

Authors:  Jasmin Zeindler; Savas Deniz Soysal; Salvatore Piscuoglio; Charlotte K Y Ng; Robert Mechera; Andrej Isaak; Walter Paul Weber; Simone Muenst; Christian Kurzeder
Journal:  Front Med (Lausanne)       Date:  2019-09-13

3.  Expression of PD-L1 in triple-negative breast cancer based on different immunohistochemical antibodies.

Authors:  Woo Young Sun; Yu Kyung Lee; Ja Seung Koo
Journal:  J Transl Med       Date:  2016-06-10       Impact factor: 5.531

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.